Basepaws

📍 Torrance, United States🗓 Founded 2017👥 60 employees💰 Last funded Jan 2020
Biotechnology Research🌐 basepaws.com
Website LinkedIn
Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. Basepaws is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA. On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws. The acquisition was first announced on June 7th, and the financial terms of the transaction were not disclosed. “The addition of Basepaws will enhance our portfolio in the precision animal health space and inform our future pipeline of petcare innovations. Working together, we can continue to provide veterinarians and pet owners with more comprehensive ways to proactively manage the health, wellness and quality of care for their animals.” - said Zoetis CEO Kristin Peck. 
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Israel
1
Investor activity2019–2020 · investors recorded per year
2019220201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Basepaws?
Basepaws has 3 investors on record on gritt.io, 3 mid-stage.
When did Basepaws last raise funding?
The most recent investment in Basepaws recorded on gritt.io was in January 2020.
When was Basepaws founded?
Basepaws was founded in 2017.
What industry is Basepaws in?
Basepaws operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Basepaws based?
Basepaws is headquartered in Torrance, United States.